Pila Pharma AB (publ) (STO:PILA)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.170
-0.095 (-7.51%)
Jul 24, 2026, 5:13 PM CET

Pila Pharma AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.131.130.791.461.880.72
Revenue Growth
17.63%42.64%-46.01%-22.21%161.49%-
Gross Profit
1.131.130.791.461.880.68
Operating Income
-8.03-8.03-8.11-6.39-8.89-9.26
Net Income
-17-17-11.24-9.93-26.78-17.21
Earnings Per Share
-0.40-0.40-0.44-0.47-1.55-1.32
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0005.957.2428.21
Total Debt
000000
Net Cash (Debt)
-0-0-05.957.2428.21
Net Cash Growth
----17.79%-74.33%1904.68%
Net Cash Per Share
---0.280.422.16

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-6.63-6.63-7.82-4.85-9.09-9.36
Capital Expenditures
0--000
Free Cash Flow
-6.63-6.63-7.82-4.85-9.09-9.36
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%94.68%
Operating Margin
-713.00%-713.00%-1026.62%-436.99%-472.69%-1287.57%
Pretax Margin
-364.06%-1509.00%-1423.15%-678.73%-1423.74%-2392.46%
Profit Margin
-1509.00%-1509.00%-1423.15%-678.73%-1423.74%-2392.46%
FCF Margin
-588.55%-588.55%-990.39%-331.71%-483.37%-1301.95%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
51.2976.94128.7826.0230.29152.22